Alice Robertson
Overview
Explore the profile of Alice Robertson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robertson A
Nurs Stand
. 2016 Sep;
10(10):46.
PMID: 27654209
It has been with confused feelings that I followed the recent coverage of the government's supposedly alarmist announcement that seven brands of contraceptive pill increase the risk of blood clots.
2.
Painter W, Robertson A, Trost L, Godkin S, Lampert B, Painter G
Antimicrob Agents Chemother
. 2012 Mar;
56(5):2726-34.
PMID: 22391537
CMX001 is a novel, broad-spectrum lipid antiviral conjugate (LAC) that produces high intracellular levels of the active antiviral agent cidofovir diphosphate (CDV-PP). Study CMX001-102 was a randomized, double-blind, placebo-controlled, parallel...
3.
Lanier R, Trost L, Tippin T, Lampert B, Robertson A, Foster S, et al.
Viruses
. 2011 Apr;
2(12):2740-2762.
PMID: 21499452
CMX001 (phosphonic acid, [[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]mono[3-(hexadecyloxy)propyl] ester) is a lipid conjugate of the acyclic nucleotide phosphonate, cidofovir (CDV). CMX001 is currently in Phase II clinical trials for the prophylaxis of human cytomegalovirus...
4.
Rice A, Adams M, Wallace G, Burrage A, Lindsey S, Smith A, et al.
Viruses
. 2011 Mar;
3(1):47-62.
PMID: 21373379
CMX001, a lipophilic nucleotide analog formed by covalently linking 3-(hexdecyloxy)propan-1-ol to cidofovir (CDV), is being developed as a treatment for smallpox. In the absence of human cases of smallpox, new...
5.
Rice A, Adams M, Lampert B, Foster S, Robertson A, Painter G, et al.
Viruses
. 2011 Mar;
3(2):63-82.
PMID: 21369346
CMX001, a lipophilic nucleotide analog formed by covalently linking 3-(hexdecyloxy)propan-1-ol to cidofovir (CDV), is being developed as a treatment for smallpox. CMX001 has dramatically increased potency versus CDV against all...
6.
Parker S, Siddiqui A, Oberle C, Hembrador E, Lanier R, Painter G, et al.
Virology
. 2008 Dec;
385(1):11-21.
PMID: 19100593
The intranasal lethal mousepox model employing the A/Ncr mouse strain is used to evaluate anti-orthopoxvirus therapies. These infections mimic large droplet transmission and result in 100% mortality within 7-10 days...
7.
Parker S, Schriewer J, Oberle C, Robertson A, Lanier R, Painter G, et al.
Antivir Ther
. 2008 Dec;
13(7):863-73.
PMID: 19043920
Background: The emergence of human monkeypox and the potential use of recombinant variola and monkeypox viruses as biological terrorist agents have necessitated the development of therapeutic and prophylactic therapies. The...
8.
Parker S, Touchette E, Oberle C, Almond M, Robertson A, Trost L, et al.
Antiviral Res
. 2007 Oct;
77(1):39-49.
PMID: 17904231
In the 21st century we are faced with the potential use of natural or recombinant VARV and MPXV as biological weapons, and the emergence of human MPXV. Such an occurrences...
9.
Quenelle D, Prichard M, Keith K, Hruby D, Jordan R, Painter G, et al.
Antimicrob Agents Chemother
. 2007 Aug;
51(11):4118-24.
PMID: 17724153
The combination of ST-246 and hexadecyloxypropyl-cidofovir or CMX001 was evaluated for synergistic activity in vitro against vaccinia virus and cowpox virus (CV) and in vivo against CV. In cell culture...